Creatinine Assay Market to Reach $878M by 2029 | MMR
Global Creatinine Assay Market Projected to Reach USD 878 Million as Renal Diagnostics, Chronic Kidney Disease Management, and Automated Enzymatic Testing Reshape Clinical Laboratories Maximize Market Research, a distinguished global market intelligence and healthcare business advisory firm, has released an extensive, forward-looking strategic analysis examining the clinical evolution, diagnostic technology adoption, and commercial roadmap of the Global Creatinine Assay Market. Valued at USD 632.36 million in 2022, the global creatinine assay market is projected to expand at a steady compound annual growth rate (CAGR) of 4.80 percent through the forecast period, advancing toward an estimated market valuation of USD 878.00 million by 2029. The newly published assessment details how diagnostic laboratories, clinical research facilities, and healthcare networks worldwide are undergoing an operational transformation in renal function assessment. As chronic kidney disease (CKD), diabe...